Medical device cybersecurity is no longer an optional feature or a last-minute checkbox prior to market entry. Hosted by Etienne Nichols, this episode features Chris Gates, founder and CEO of arsMedSecurity, who delivers a practical, engineering-first perspective on embedding security directly into the development lifecycle. Gates highlights that deferring cybersecurity efforts until the end of development leads to severe financial penalties, extended regulatory delays, and potential company failure.
The discussion demystifies common misconceptions held by executive teams and "bean counters," such as the myth that off-network devices or small companies are exempt from cyber threats. Under current FDA expectations and the eStar submission process, any medical device containing software is subject to stringent pre-market cybersecurity requirements. Gates illustrates how unexpected 180-day regulatory holds impact a company's daily burn rate, showing that proactive security measures are far cheaper than reactive fixes.
Looking ahead, the conversation explores the evolving threat landscape driven by Large Language Models (LLMs) and advanced exploits that reduce vulnerability exploitation windows from years to minutes. Gates provides concrete steps for medical device manufacturers to take control of their product security, emphasizing early threat modeling, continuous risk management, and the alignment of software development SOPs with recognized international standards.
We want to hear from you! What cybersecurity challenges is your team currently navigating during product development? Send your questions, feedback, or topic suggestions directly to us at podcast@greenlight.guru. Every email is reviewed by our team, and we regularly incorporate listener-submitted questions into upcoming episodes and expert Q&A segments.
This episode is brought to you by Greenlight Guru.